Molecules involved in cell death and peripheral tolerance.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Current Opinion in Immunology

• Publication date

  1997-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0952-7915(97)80184-7PMID 9492984
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RAIDD is a new 'death' adaptor molecule

  1997cited by this paper
• Inhibition of death receptor signals by cellular FLIP

  1997cited by this paper
• DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis.

  1997cited by this paper
• The role of Fas in autoimmune diabetes.

  1997cited by this paper
• Casper is a FADD- and caspase-related inducer of apoptosis.

  1997cited by this paper
• TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95).

  1997cited by this paper
• A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis.

  1997cited by this paper
• Apoptosis: Placing death under control

  1997cited by this paper
• TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL.

  1997cited by this paper
• Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts.

  1997cited by this paper
• Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3.

  1997cited by this paper
• LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing.

  1997cited by this paper
• Multiple species of CPP32 and Mch2 are the major active caspases present in apoptotic cells

  1997cited by this paper
• Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors.

  1997cited by this paper
• CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP.

  1997cited by this paper
• Daxx, a novel Fas-binding protein that activates JNK and apoptosis.

  1997cited by this paper
• The role of the Caspase family of cysteine proteases in apoptosis.

  1997cited by this paper
• Affinity labeling displays the stepwise activation of ICE-related proteases by Fas, staurosporine, and CrmA-sensitive caspase-8

  1997cited by this paper
• Apoptosis by death factor.

  1997cited by this paper
• The Receptor for the Cytotoxic Ligand TRAIL

  1997cited by this paper
• CASH, a Novel Caspase Homologue with Death Effector Domains*

  1997cited by this paper
• The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis

  1997cited by this paper
• Death substrates come alive

  1997cited by this paper
• Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.

  1997cited by this paper
• TRAIL‐R2: a novel apoptosis‐mediating receptor for TRAIL

  1997cited by this paper
• Interaction of CED-4 with CED-3 and CED-9: A Molecular Framework for Cell Death

  1997cited by this paper
• FLAME-1, a Novel FADD-like Anti-apoptotic Molecule That Regulates Fas/TNFR1-induced Apoptosis*

  1997cited by this paper
• I-FLICE, a Novel Inhibitor of Tumor Necrosis Factor Receptor-1- and CD-95-induced Apoptosis*

  1997cited by this paper
• Interaction between the C. elegans cell-death regulators CED-9 and CED-4

  1997cited by this paper
• Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction

  1997cited by this paper
• Interaction and Regulation of Subcellular Localization of CED-4 by CED-9

  1997cited by this paper
• FLICE is activated by association with the CD95 death‐inducing signaling complex (DISC)

  1997cited by this paper
• Identifying the molecular control of T-cell death; on the hunt for killer genes.

  1997cited by this paper
• An antagonist decoy receptor and a death domain-containing receptor for TRAIL.

  1997cited by this paper
• Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation.

  1997cited by this paper
• Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked

  1997cited by this paper
• Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death.

  1996cited by this paper
• Lamin proteolysis facilitates nuclear events during apoptosis

  1996cited by this paper
• Signal Transduction by DR3, a Death Domain-Containing Receptor Related to TNFR-1 and CD95

  1996cited by this paper
• Suppression of TNF-alpha-induced apoptosis by NF-kappaB.

  1996cited by this paper
• A death-domain-containing receptor that mediates apoptosis

  1996cited by this paper
• Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice

  1996cited by this paper
• Human ICE/CED-3 protease nomenclature.

  1996cited by this paper
• Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death.

  1996cited by this paper
• Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases.

  1996cited by this paper
• Different Interleukin-1β Converting Enzyme (ICE) Family Protease Requirements for the Apoptotic Death of T Lymphocytes Triggered by Diverse Stimuli

  1996cited by this paper
• In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains.

  1996cited by this paper
• TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways.

  1996cited by this paper
• Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family.

  1996cited by this paper
• Fas and the art of lymphocyte maintenance

  1996cited by this paper
• Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B.

  1996cited by this paper
• Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell Death

  1996cited by this paper
• A license to kill.

  1996cited by this paper
• Nerve growth factor is an autocrine survival factor for memory B lymphocytes.

  1996cited by this paper
• Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice.

  1996cited by this paper
• FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex.

  1996cited by this paper
• ICE-LAP3, a Novel Mammalian Homologue of the Caenorhabditis elegans Cell Death Protein Ced-3 Is Activated during Fas- and Tumor Necrosis Factor-induced Apoptosis (*)

  1996cited by this paper
• TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex.

  1996cited by this paper
• Specific Cleavage of α-Fodrin during Fas- and Tumor Necrosis Factor-induced Apoptosis Is Mediated by an Interleukin-1β-converting Enzyme/Ced-3 Protease Distinct from the Poly(ADP-ribose) Polymerase Protease*

  1996cited by this paper
• Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease.

  1996cited by this paper
• The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice.

  1996cited by this paper
• CPP32/Apopain Is a Key Interleukin 1 Converting Enzyme-like Protease Involved in Fas-mediated Apoptosis (*)

  1996cited by this paper
• Greatly accelerated lymphadenopathy and autoimmune disease in lpr mice lacking tumor necrosis factor receptor I.

  1996cited by this paper
• Prevention of Islet Allograft Rejection with Engineered Myoblasts Expressing FasL in Mice

  1996cited by this paper
• TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB.

  1996cited by this paper
• An essential role for NF-kappaB in preventing TNF-alpha-induced cell death.

  1996cited by this paper
• Tumor necrosis factor receptor p55 mediates deletion of peripheral cytotoxic T lymphocytes in vivo

  1996cited by this paper
• Suppression of TNF-α-Induced Apoptosis by NF-κB

  1996cited by this paper
• An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death

  1996cited by this paper
• TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB

  1996cited by this paper
• Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis

  1995cited by this paper
• FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis.

  1995cited by this paper
• A Novel Protein That Interacts with the Death Domain of Fas/APO1 Contains a Sequence Motif Related to the Death Domain (*)

  1995cited by this paper
• Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

  1995cited by this paper
• Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity.

  1995cited by this paper
• The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation.

  1995cited by this paper
• CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway

  1995cited by this paper
• Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme.

  1995cited by this paper
• Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta.

  1995cited by this paper
• bcl-2 transgenic Lpr mice show profound enhancement of lymphadenopathy.

  1995cited by this paper
• Fas ligation induces apoptosis of CD40-activated human B lymphocytes

  1995cited by this paper
• Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock.

  1995cited by this paper
• Fas- and Tumor Necrosis Factor-induced Apoptosis Is Inhibited by the Poxvirus crmA Gene Product (*)

  1995cited by this paper
• Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.

  1995cited by this paper
• Induction of apoptosis in mature T cells by tumour necrosis factor

  1995cited by this paper
• Multiple pathways originate at the Fas/APO‐1 (CD95) receptor: sequential involvement of phosphatidylcholine‐specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal.

  1995cited by this paper
• Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment.

  1995cited by this paper
• Fas and Fas ligand: lpr and gld mutations.

  1995cited by this paper
• Bcl‐2 and Fas/APO‐1 regulate distinct pathways to lymphocyte apoptosis.

  1995cited by this paper
• Interleukin‐2 Deficient Mice: A New Model to Study Autoimmunity and Self‐Tolerance

  1995cited by this paper
• FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway.

  1995cited by this paper
• A role for CD95 ligand in preventing graft rejection

  1995cited by this paper
• The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death.

  1994cited by this paper
• Antigen nonspecific effect of major histocompatibility complex haplotype on autoantibody levels in systemic lupus erythematosus-prone lpr mice.

  1993cited by this paper
• lnterleukin-2 programs mouse αβ T lymphocytes for apoptosis

  1991cited by this paper
• Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis.

  1991cited by this paper

• Use of Cell-Penetrating Peptides to Enhance Delivery Performance

  2020cites this paper
• Protein transduction therapy into cochleae via the round window niche in guinea pigs

  2016cites this paper
• Mechanisms of apoptosis in irradiated and sunitinib-treated follicular thyroid cancer cells

  2014cites this paper
• Trim27-deficient mice are susceptible to streptozotocin-induced diabetes☆

  2013cites this paper
• Novel approaches to modulate apoptosis resistance: basic and clinical implications in the treatment of chronic lymphocytic leukemia (CLL).

  2012cites this paper
• Cell Cycle Regulation and Systemic Lupus Erythematosus

  2011cites this paper
• Apoptotic molecular mechanisms implicated in autoimmune diseases.

  2009cites this paper
• Extradigestive manifestations of IBD in pediatrics.

  2009cites this paper
• Dissecting the roles of the non-canonical NF-kB signaling in the pathogenesis of lymphoma and autoimmunity.

  2008cites this paper
• The Apoptotic Pathway Contributing to the Deletion of Naive CD8 T Cells during the Induction of Peripheral Tolerance to a Cross-Presented Self-Antigen1

  2008cites this paper
• Cell cycle inhibitors in T cell tolerance and autoimmunity control

  2007cites this paper
• NF-KappaB2 is an Autoimmunity Regulator and Its Mutation Leads to Lymphomagenesis in Mice

  2006cites this paper
• Role of cell cycle regulator E2F1 in regulating CD8 T cell responses during acute and chronic viral infection.

  2004cites this paper
• Tolerance induction and endogenous regeneration of pancreatic beta-cells in established autoimmune diabetes.

  2004cites this paper
• MONOGENIC MODEL FOR AUTOIMMUNE DISEASES: MOLECULAR BASIS OF AUTOIMMUNE POLYENDOCRINOPATHY - CANDIDIASIS - ECTODERMAL DYSTROPHY (APECED)

  2003cites this paper
• MODEL FOR AUTOIMMUNE DISEASES : CULAR BASIS OF AUTOIMMUNE NOPATHY-CANDIDIASIS-ECTODERMAL DYSTROPHY ( APECED )

  2003cites this paper
• Apoptosis and Apoptosis-Related Molecules in the Submandibular Gland of the Nonobese Diabetic Mouse Model for Sjögren’s Syndrome: Limited Role for Apoptosis in the Development of Sialoadenitis

  2003cites this paper
• Resistance to Fas-mediated cell death in BeWo and NJG choriocarcinoma cell lines: implications in immune privilege.

  2003cites this paper
• Characterizing a soluble survival signal for activated lymphocytes from CD14+ cells

  2002cites this paper
• Modulating apoptosis pathways in low-grade B-cell malignancies using biological response modifiers.

  2002cites this paper
• Expression of Bcl‐2 in inclusion body myositis

  2002cites this paper
• Constitutive Expression of the Adenovirus E3-14.7K Protein Does Not Prolong Adenovirus Vector DNA Persistence but Protects Mice Against Lipopolysaccharide-Induced Acute Hepatitis

  2002cites this paper
• Modulating apoptosis pathways in low-grade B-cell malignancies using biological response modifiers.

  2002cites this paper
• Autoimmunity and apoptosis: the Crohn's connection.

  2001cites this paper
• The NOD Mouse as a Model of SLE

  2001cites this paper
• The Globular Heads of C1q Specifically Recognize Surface Blebs of Apoptotic Vascular Endothelial Cells1

  2001cites this paper
• Veto activity of activated bone marrow does not require perforin and Fas ligand.

  2001cites this paper
• Differential role of CD80 and CD86 molecules in the induction and the effector phases of allergic rhinitis in mice.

  2001cites this paper
• Expression of costimulatory CD80/CD86‐CD28/CD152 molecules in nasal mucosa of patients with perennial allergic rhinitis

  2001cites this paper
• Autoimmunity and Apoptosis: The Crohn's Connection

  2001cites this paper
• Bladder cancer cells acquire competent mechanisms to escape Fas-mediated apoptosis and immune surveillance in the course of malignant transformation

  2001cites this paper
• A soluble survival signal from CD14+ cells and its possible role in the pathogenesis of rheumatoid arthritis

  2001cites this paper
• The role of costimulation and adjuvants in the development of T cell effector and memory responses

  2001cites this paper
• A GTP-binding adapter protein couples TRAIL receptors to apoptosis-inducing proteins

  2001cites this paper
• Caspase-10 mutations in the autoimmune lymphoproliferative syndrome type II

  2000cites this paper
• Cell-cycle regulation in immunity, tolerance and autoimmunity.

  2000cites this paper
• Antioxidants : Protection versus apoptosis

  2000cites this paper
• Mechanisms of apoptosis.

  2000cites this paper
• Antigen-Specific Induction of Peripheral T Cell Tolerance in Vivo by Codelivery of DNA Vectors Encoding Antigen and Fas Ligand

  2000cites this paper
• Strategies to evaluate metabolic stress and catabolism by means of immunological variables.

  2000cites this paper
• Roles of caspases in apoptosis, development, and cytokine maturation revealed by homozygous gene deficiencies.

  2000cites this paper
• Apoptosis and autoimmunity: Complement deficiency and systemic lupus erythematosus revisited

  2000cites this paper
• Danger and OX40 Receptor Signaling Synergize to Enhance Memory T Cell Survival by Inhibiting Peripheral Deletion1

  2000cites this paper
• Alloreactivity and apoptosis in graft rejection and transplantation tolerance

  2000cites this paper
• Lecture Mechanisms of Apoptosis

  2000cites this paper
• Autoimmunity and autoimmune disease of the eye.

  1999cites this paper
• Inhibition of Interleukin 2 Signaling and Signal Transducer and Activator of Transcription (Stat)5 Activation during T Cell Receptor–Mediated Feedback Inhibition of T Cell Expansion

  1999cites this paper
• Breakdown of self-tolerance and the pathogenesis of autoimmunity.

  1999cites this paper
• Survival by Inhibiting Peripheral Deletion Synergize to Enhance Memory T Cell Danger and OX40 Receptor Signaling

  1999cites this paper
• Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment.

  1999cites this paper
• Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations

  1999cites this paper
• Inhibition of tyrosine phosphatases antagonizes CD95-mediated apoptosis.

  1999cites this paper